Inari Medical (Ticker: NARI) is a medical device company that specializes in the development and commercialization of innovative products for the treatment of venous diseases. The company's flagship product, the FlowTriever System, is designed to remove blood clots from the deep veins of the legs, offering a minimally invasive alternative to traditional clot removal procedures. Inari Medical is dedicated to improving patient outcomes and revolutionizing the field of venous thromboembolism treatment.

In terms of technical analysis, the stock of Inari Medical has recently broken down from a major support level. This indicates a significant shift in the stock's trend, with the stock price falling below a key level of support. The breakdown suggests a potential bearish bias in the market, with selling pressure outweighing buying interest.

Given the breakdown from the major support level, investors and traders should exercise caution and closely monitor any potential continuation or reversal signals. It is important to assess the market conditions and consider additional factors before making any significant investment decisions.